More open positions are now available! Follow the link below to see all of the new career opportunities at Wheeler Bio, Inc. including positions in: ?? Analytical Development ?? GMP Manufacturing ?? Project Managment ?? Business Development Come join the Wheeler Team and be part of the new #CDMO paradigm! #hiring #analytical #development #gmp #manufacturing #PMO #BD
关于我们
Wheeler Bio is a pioneering Contract Development and Manufacturing Organization (CDMO) focused on accelerating the discovery-to-development process for biopharmaceutical companies. Through a unique partnering model, we aim to address industry bottlenecks by facilitating smoother transitions between discovery and development phases, empowering innovators to bring novel antibody and antibody-like therapeutics to market with precision, speed, and optimized cost without ever compromising quality. Wheeler Bio specializes in mammalian cell line and process development, GLP Tox material supply, and CGMP clinical supply, leveraging our Portable CMC? platform to streamline the pathway from innovation to clinical trials. Our approach has been purposefully designed to reduce lifecycle challenges, enhance efficiency, and foster lasting collaborations within the biopharma industry.
- 网站
-
https://www.wheelerbio.com/
Wheeler Bio, Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 51-200 人
- 总部
- Oklahoma City，Oklahoma
- 类型
- 私人持股
- 创立
- 2020
- 领域
- Cell Line Development、Process Development、Analytical Development、Tech Transfer、CMC、Process Characterization、Formulation Development、GMP Manufacturing、Pharmaceutical Manufacturing、Clinical Manufacturing、Contract Manufacturing、Biotechnology、Pharmaceuticals、Biologics、Cell Banking 、Drug Substance、Life Science、Monoclonal Antibodies、Antibody Development和Therapeutic Development
地点
Wheeler Bio, Inc.员工
动态
-
Wheeler Bio, Inc. is currently seeking manufacturing professionals at several levels for immediate hire in Oklahoma City. The job descriptions are here: https://lnkd.in/eXgwMzY9 Come join a growing CDMO with a great team of professionals!
-
I'm excited to be in San Diego attending at BioProcess International US West 2025 this March 19-21!?? Looking forward to cutting-edge science, networking, strategies & breakthroughs across 5 dedicated content tracks through every phase of bioprocessing. Let’s meet to discuss how Wheeler can help you slash time from bench to bedside to deliver safe and effective therapies to patients.?? Share what you're most looking forward to at #BPIWest in the comments! Will I see you there? To join me click here ?? https://lnkd.in/g5BUD9Az #BioProcessInternational #BPI #Bioprocessing #SanDiego Informa Connect
-
-
Thrilled at this great next step to build the Oklahoma technology base and a huge step forward for biotechnology ecosystem in OKC. Wheeler Bio, Inc. has leased approximately 60,000 sq feet in the Convergence OKC facility to expand our scientific and mammalian cell culture/antibody therapeutic manufacturing capabilities. Congratulations to Robinson Park and the OKC Innovation District !
Today marked an exciting milestone for Oklahoma City with the Ribbon Cutting Ceremony of Convergence OKC in the OKC Innovation District! The public gathered to hear remarks from Mayor David Holt, Investor Dick Tanenbaum of Gardner Tanenbaum, Developer Mark Beffort of Robinson Park, Megan Gelmers, MBA, Director of Investments and Development at Robinson Park, and Jeffrey Seymour, CEcD, President and CEO of The Innovation District. Convergence OKC stands as a hub for innovation and collaboration, driving Oklahoma's emerging industries forward. We’re thrilled to see this transformative project come to life and can't wait to see its impact on our community! ?? #ConvergenceOKC #InnovationDistrict #OklahomaCity #Collaboration #Innovation #RobinsonPark #GardnerTanenbaum #OKC #LingoConstructionServices
-
-
2024 was quite a year! I have been at Wheeler Bio, Inc. for approximately ninety days and it feels like I joined the team yesterday. I am extremely impressed with the Wheeler team and their passion for science and for collaborating with innovative partners throughout the biopharmaceutical industry. Wheeler has completed a significant amount of foundational scientific work that supports our Modular CMC approach that enables rapid transition from gene to stable pools to delivering toxicology material and, in parallel, clone selection, to master and working cell banks to cGMP release of Phase 1 product. We are eager to partner with innovative biotechnology companies to rapidly advance antibody-based therapies beginning from a gene or if you have an immediate need for clinical manufacturing, we can support your program. Our team and capabilities are strong and expanding. To experience a "drones eye view" of our capabilities please enjoy this video. https://lnkd.in/eek8yfcB We look forward to expanding our capabilities, partner and investor base in 2025! Wheelerbio.com
-
I'm looking forward to attending Biotech Showcase 2025! Join me in San Francisco, January 13–15, 2025 https://lnkd.in/gj4b4vS5 #BiotechShowcase Informa Connect
-
-
The whole Wheeler Bio, Inc. family would like to wish everyone a happy holiday season! We hope that you all can take this time to turn your attention to those that matter most in your lives and enjoy the end of 2024 with family and friends. As the team winds down in preparation for the new year, we also want to sincerely thank all of our investors, clients, partners, and supporters throughout the industry for making 2024 such a transformative year for Wheeler. Your support has set us up for continued success and allows us to relentlessly pursue our mission of serving patients in need. See you in 2025!
-
-
Wheeler Bio, Inc. will be attending JP Morgan 2025! Our CEO, Patrick Lucy, and CCO, Sheli Streck, will be in San Francisco Jan. 13-16 to attend the 43rd Annual JPM Healthcare Conference to tell the Wheeler story and share our vision for the new year. After a transformative 2024, we can't wait to share our latest advancements, reconnect with our old colleagues, and make new friends as we all come together to solve today's most pressing health challenges. Follow the link below to reach out and schedule a meeting with us! ?? wheelerbio.com/contact/ #JPM2025 #Healthcare #Biotech #Therapeutics #Conference
-
-
Next week, the Wheeler Bio, Inc. team will be attending Antibody Engineering & Therapeutics 2024 in San Diego! Reach out to Aaron Pilling, PhD or Ken Meek to schedule a meeting and learn more about our modular, client-focused approach to CMC development and clinical manufacturing. Also, don't miss Aaron's talk on Wednesday at 12pm PT to get the latest updates on Wheeler's expansion in capabilities to further accelerate clinical progression for biologics innovators. See you there! #GMP #CMC #Discovery #Biologics #Antibody